CEA overexpress in several type of tumor which associate with cell proliferation and tumor progression is a broad-spectrum tumor marker that can be used to assess efficacy, monitor disease progression, and predict prognosis in lung cancer, colorectal cancer, breast cancer, and other cancers [37–40]. This evidence concerns the gene CEACAM5 and neoplasm.